Financials
Income statement
Fiscal date | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total reported revenue | 39.7B | 40.0B | 41.1B | 63.5B |
Cost of revenue | 17.3B | 16.0B | 15.7B | 18.6B |
Gross profit | 22.4B | 24.0B | 25.3B | 44.9B |
Operating expense | ||||
Research & development | 294.4M | 181.2M | 56.2M | 65M |
Selling general and admin | 2.2B | 2.1B | 2.3B | 7.3B |
Other operating expenses | 5.2B | 6.6B | 5.2B | 3.8B |
Operating income | 10.9B | 11.6B | 14.4B | 30.1B |
Non operating interest income | ||||
Income | 17.8M | 3.0M | 2.2M | 62M |
Expense | 1.2B | 1.4B | 1.4B | 596M |
Other income expense | — | — | — | — |
Pretax income | 11.5B | 10.2B | 13.8B | 30.8B |
Tax provision | 3.0B | 2.8B | 4.2B | 8.2B |
Net income | 8.6B | 7.4B | 9.7B | 22.6B |
Basic EPS | 7.1 | 6.2 | 7.7 | 13.0 |
Diluted EPS | 7.1 | 6.2 | 7.6 | 13.0 |
Basic average shares | 1.2B | 1.2B | 1.2B | 2.0B |
Diluted average shares | 1.2B | 1.2B | 1.2B | 2.0B |
EBITDA | 16.7B | 16.3B | 19.0B | 36.7B |
Net income from continuing op. | 8.6B | 7.4B | 9.7B | 22.6B |
Minority interests | -22M | 105M | -656M | -1.5B |
Preferred stock dividends | 0 | 0 | 0 | 0 |